UPDATE 1-Valeant trumps Endo with increased bid for Salix Pharma
March 16, 2015 at 08:51 AM EDT
March 16 (Reuters) - Valeant Pharmaceuticals International Inc said it increased its offer for Salix Pharmaceuticals Inc to $10.96 billion in cash, topping Endo International Plc's bid of $10.93 billion in cash and stock for the bowel drug maker.